Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

125.61
BATS BZX Real-Time Price
As of 3:38pm ET
 -0.30 / -0.24%
Today’s Change
92.56
Today|||52-Week Range
141.86
+29.02%
Year-to-Date

Today’s Trading

Previous close125.91
Today’s open126.18
Day’s range122.71 - 128.27
Volume1,463,336
Average volume (3 months)1,667,938
Market cap$30.4B
Data as of 3:38pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)-82.40%
Earnings growth (this year)+17.30%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+17.00%
P/E ratio358.7
Price/Sales5.29
Price/Book3.32

Competitors

 Today’s
change
Today’s
% change
REGNRegeneron Pharmaceut...-8.67-2.53%
BAXBaxter International...-0.10-0.13%
INCYIncyte Corp-0.87-1.17%
BMRNBiomarin Pharmaceuti...+0.40+0.49%
Data as of 3:38pm ET, 04/18/2019

Financials

Next reporting dateApril 25, 2019
EPS forecast (this quarter)$2.19
Annual revenue (last year)$4.1B
Annual profit (last year)$77.6M
Net profit margin1.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Boston, Massachusetts

Forecasts